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Health disparities, including substantial differences in health status and quality of health 
care across racial, ethnic, socioeconomic and sexual orientation groups, remain a significant 
concern in the United States.  An examination of health disparities and their causes is essential so 
that strategies to close these gaps can be developed. 
   Coronary artery disease (CAD) is the leading cause of death for all racial groups in the 
U.S.;1  but blacks are disproportionately affected compared to whites.  Studies demonstrate that 
blacks are more likely to die from CAD—and die at a younger age—than whites.  This increased 
mortality rate likely represents a complex interaction of different health as well as healthcare-
seeking behaviors and different risk factor profiles for blacks and whites.  Lower socioeconomic 
status and differential medical treatment based on race may also contribute.1-4   
 In sharp contrast to these concerning findings, several studies have demonstrated that 
black patients are less likely to have significant angiographically-detected CAD than whites.  
This is an interesting and important finding, given that angiography is the “gold-standard” 
diagnostic test of the presence and severity of CAD and is used to make definitive patient-
specific treatment decisions.  There are no studies to date that have adequately assessed causes 
for this paradoxical finding.  
 The goal of this master’s paper was to examine this topic through two distinct 
approaches.  First, through a literature review, I attempted to systematically find and examine 
studies which have addressed racial differences in angiographic findings to determine the current 
quality and magnitude of the evidence that supports the conclusion that blacks have a lower rate 
of CAD than whites.  Through my review, I found that several studies have examined this topic, 
and although the quality of most is moderate, the majority have found a substantially lower 
likelihood of angiographic disease in black patients compared to whites.   
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Second, through original research using a clinical database at UNC Hospitals, my 
colleagues and I attempted to examine a potential explanation for black-white differences in 
angiographic CAD.  Hypertension is more prevalent, and its cardiac effects more deleterious, in 
blacks compared to whites.  Hypertensive heart disease may mimic the signs and symptoms of 
CAD despite a lack of significant coronary plaque and therefore lead to angiography for 
suspicion of CAD.  We found that hypertension is associated with black-white differences in 
angiography.  Black patients are far less likely to have disease than whites in the subset of 
patients with hypertension; however, black and white rates of disease are nearly identical in the 
subset of patients without hypertension. 
 This research represents a summary of the literature on racial disparities in angiographic 
findings in addition to an initial exploration of the reasons behind these findings.  This paper 
provides evidence that there is a significant difference in rates of angiographic CAD between 
white and black patients and that hypertension may account for this difference.  The most 
important implications of this paper are for future research; a determination of which aspects of 
hypertension are leading to negative angiographic evaluations and how this information can 
contribute to clinical decision-making could help decrease the rate of invasive negative studies 
and improve the usefulness of angiography in black patients, both of which could provide 
tangible health benefits to this population. 
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Do blacks have a lower burden of angiographic coronary artery disease than whites?: 
A review of the literature 
ABSTRACT: 
Introduction.  Black Americans have a higher mortality rate from coronary artery disease 
(CAD) than whites, which may reflect a greater risk factor burden, increased barriers to care, 
lower socioeconomic status and differences in treatment.  However, several studies have shown 
that despite a higher mortality rate and clinical burden of disease, black patients referred for 
angiography are less likely to have detected coronary stenoses than whites.  This review is an 
attempt to summarize the evidence from the literature that examines black-white differences in 
angiographic disease. 
Methods.  A systematic search strategy was used to identify articles which address the topic of 
interest.  Eligible articles were reviewed for quality using a pre-specified and validated method 
of quality assessment.  Important study characteristics and study findings were also examined for 
included articles.  
Results.  Eight articles met all eligibility criteria and were included in this review.  The majority 
(6) of the articles were given moderate quality ratings for internal validity, while the applicability 
of the studies to the key question of the review varied.  Six of the articles reported a significantly 
lower rate of angiographic CAD in blacks compared to whites, one reported mixed findings and 
a single study found no differences between the race groups. 
Conclusions.  There is fair evidence that black patients referred for angiography are less likely 
than whites to have significant CAD.  This finding has important implications for future research 
to examine explanations for this finding as well as the clinical and prognostic value of 
angiography in blacks compared to whites. 
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INTRODUCTION 
Coronary artery disease (CAD) is the leading cause of death in the United States;1   
however, mortality rates continue to decline in an era of improved diagnostic techniques and 
treatments for heart disease and its risk factors.  Despite this optimistic trend, gains for whites 
over the past half-century have been disproportionately greater than gains for blacks and 
significant racial disparities in CAD outcomes have worsened.2, 5   Black Americans have a 
significantly higher mortality rate from CAD than their white counterparts in addition to an 
appreciably younger average age of ischemic heart disease death.1-4  
 The mortality differences between these racial groups have been attributed to a number of 
factors.  Compared to whites, black Americans have a higher burden of risk factors for CAD 
including hypertension, diabetes and obesity.2, 6, 7   Moreover, blacks are more likely to face 
socioeconomic barriers to heathcare access and display less healthcare-seeking behavior.2-4, 7  
Studies also reveal that black patients may be less likely to receive appropriate care for CAD, 
particularly invasive treatment,2, 8-11  and this may also contribute to poorer outcomes in this 
group. 
 Despite this multitude of factors contributing to racial disparities in CAD outcomes and 
death, several authors have reported a perplexing finding: Blacks undergoing angiography for 
clinical suspicion of CAD are less likely to have stenosis in the coronary arteries and therefore 
have an overall lower burden of angiographic disease.5, 12-16  This finding adds another layer of 
complexity to racial disparities in CAD.  Eliminating racial disparities in CAD outcomes will 
certainly involve improving risk factor identification and control, increasing access to care, and 
addressing differences in healthcare quality in blacks, but it may also be necessary to explore 
explanations for why CAD outcomes are worse in this group despite a lower burden of disease. 
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 Before testing hypotheses that might explain this paradoxical finding, it is essential to 
review and summarize the evidence on racial disparities in angiographic CAD.  The aim of this 
literature review is to examine original studies from the past two decades to assess the quality of 
the evidence and summarize the magnitude and significance of any results for studies that 
address black-white differences in angiographic findings for patients suspected of having CAD.  
METHODS 
Identification of Relevant Articles 
 The Medline/Pubmed database was searched to find and examine studies on 
angiographically-proven CAD for black and white patients.  The following combinations of key-
word searches were used: “coronary artery disease” and “African Americans,” “coronary artery 
disease” and “race” and “difference,” “coronary angiography” and “African Americans,” 
“coronary angiography” and “race,” “coronary angiography” and “black,” coronary 
angiography” and “ethnicity,” and “coronary artery disease” and “race” and “paradox.” 
In order to target the most relevant and accessible studies for this review, eligibility was 
restricted to English-language publications after 1990 with observational design, and papers 
presenting original quantitative data.  Studies also had to include a patient population undergoing 
clinically indicated coronary angiography, examine race as the exposure of interest, use 
angiographically-detected coronary plaque as the means of comparison and compare the 
outcomes between adequate samples of black and white patients.  
Study Selection 
 The titles of all studies retrieved for each search were initially reviewed.  If the title 
indicated that the paper may meet eligibility criteria, the abstract was reviewed.  For these 
papers, if the abstract indicated that the paper may meet eligibility criteria then the full text was 
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examined.  All papers that met inclusion criteria after review of the full-text were included in this 
literature review.  The bibliographies of the included papers were also examined for titles which 
may indicate eligible studies (then abstracts and full texts were reviewed for inclusion in a 
similar process as that outlined above).   
Data Collection Methods 
 For the studies that met inclusion criteria for this review, the main findings and important 
features (study design, description of study population, selection criteria defining study 
population, measurement methods) were abstracted and tabulated.  Each study was also assessed 
for overall quality. 
   Quality of each study was evaluated using a modified form of the McMaster University 
Quality Assessment Tool for Quantitative Studies.17, 18   Six major areas were assessed and graded 
according to the strength of the study: study design, selection, confounding, measurement, 
withdrawals and analysis.  Under each component heading, studies were given scores 
corresponding to strong (score of 1), moderate (score of 2) or weak (score of 3). 
 The quality of the study design was based on the authors’ description of important design 
elements, the relative strength of the general design used compared to other methods (for 
example, a case series is considered a relatively weak design while randomized controlled trials 
are often considered the strongest design) and the thoroughness and appropriateness of the 
design to answer the study question(s).  Selection (one component of selection bias) was 
evaluated based on the completeness of the description of selection procedures and objective and 
equal selection of participants between groups.  Confounding was assessed by both the potential 
for confounding variables and the investigators’ analytic methods for minimizing confounding.  
8 
 
Measurement was evaluated by the completeness of the description of study procedures and a 
determination of whether measurements were equal between groups (including blinding of 
assessors if appropriate), valid and reliable.  Withdrawal and drop-out (the other component of 
selection bias) was evaluated by the thoroughness of the description and explanations for drop-
out and withdrawal as well as the overall rate of attrition and differential attrition between 
groups.  The data analysis was assessed by its appropriateness to the study question and its 
adherence to important principles (such as the reporting of confidence intervals, intention-to-
treat, etc.).  These six elements were used to create a global assessment of the internal validity of 
the study.  Studies received a rating of 1 (strong) if they had four areas with strong ratings and no 
weak ratings, 2 (moderate) if they had less than four strong areas and one weak rating and 3 
(weak) if they had two or more weak rated areas. 
 The external validity of the study was assigned a similar rating.  The external validity was 
assessed by determining the applicability of each study to the defined study population of this 
literature review: black and white patients in the U.S. undergoing angiography for clinical 
suspicion of CAD. 
RESULTS 
Study Selection 
 Using the pre-defined search strategy, 585 articles were originally retrieved in the 
Medline/Pubmed database.  Of these articles, 43 original studies had titles which suggested they 
may meet inclusion criteria for this study.  Of these selections, 11 of the abstracts suggested the 
article merited a full review for inclusion in the study.  Seven of these articles met all inclusion 
criteria.  An additional 14 titles were also identified from the bibliographies of these articles (and 
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one article met all inclusion criteria), which resulted in eight articles included for full review of 
evidence and quality.  5, 12-16, 19-21   The article selection process is outlined in detail in Figure 1.19  
Basic Study Characteristics 
 The eight included articles (Table 1) represent studies designed to provide original data 
to answer the main question of this literature review: Do white and black patients undergoing 
angiography for clinical suspicion of CAD differ in burden of angiographic disease?   
 Five of these studies were retrospective cohorts, while three were prospective cohort 
studies.  The studies vary in size from 311 patients to more than 700,000.  Although all provided 
data towards the literature review topic of interest, their main study question varied, with two 
studies examining angiographic findings by race as a secondary outcome.  Peniston and 
colleagues were concerned with the variation in the likelihood of revascularization as it related to 
both race and CAD on angiograpy,14 while Afonso and colleagues determined the effect of 
ethnicity and sex on the relationship between obesity and disease severity.21   Other studies only 
addressed a subset of the population of interest for this review: Whittle, Kressin and colleagues 
only examined patients who had a positive nuclear scan,16  while Whittle, Conigliaro and 
colleagues only examined patients with an Acute Coronary Syndrome (ACS).5   Several studies 
were limited to men only.5, 14, 16  
Review of Study Quality 
 The quality of each study was evaluated on six characteristics to determine a global 
assessment of internal validity, and assessed for external validity, or applicability, to the main 
literature review question of interest.  All quality scores are summarized in Table 2. 
10 
 
 All studies were rated as moderate on the basis of study design.  Each study had a cohort 
design: five had retrospective data collection, while three were prospective.  All studies provided 
adequate descriptions of important study design features.  Each design had limitations: the 
retrospective cohorts were limited by the investigators’ inability to prospectively record 
measures for important variables (such as self-defined race, risk factor information, medical 
history information, etc.).  The prospective cohort study by Whittle, Kressin and colleagues was 
limited by an inability to contact and enroll a large number of the eligible patients as well as 
strict exclusion criteria which left a sample of less than 15% of those potentially eligible,16  and 
the study by Budoff and colleagues was limited by the inclusion of all patients (rather than the 
subset with suspected CAD) undergoing coronary angiography.12    Two of the prospective 
cohorts, as studies nested within larger cohorts, suffered from forced adherence to eligibility 
criteria for the entire cohort which hindered the investigators’ ability to enroll appropriate 
subjects.16, 20  
 The majority of the studies were rated as strong studies in the selection of patients.13-15, 20, 
21   These studies provided detailed information of enrollment procedures and selection criteria.  
Each enrolled consecutive white and black patients who were candidates for angiography over a 
period of time with minimal, but appropriate, exclusions.  The study by Whittle, Conigliaro and 
colleagues was given a moderate rating because white patients were selected by matching them 
to black patients on certain characteristics chosen by the investigators.5   The study by Whittle, 
Kressin and colleagues was also given a moderate rating because only 75.7% of the eligible 
patients were enrolled, and an additional 19% of potentially eligible patients could not be 
contacted for consent by the investigator.16  The study by Budoff and colleagues was also rated as 
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moderate due to a limited description of the selection processes as well as the exclusion of 
patients unwilling to undergo additional testing beyond coronary angiography.12  
 The studies differed widely in their ability to minimize confounding.  The relationship 
between race and angiographic outcomes in patients suspected of having CAD is likely 
confounded by several variables as there are marked differences between the races in CAD risk 
factors and process of care.2-4   Four studies were given a strong rating on minimizing 
confounding; these studies identified potential confounders and adjusted for them in their 
analysis of angiographic findings by race.5, 12, 15, 16   Three papers received weak ratings for 
confounding as they did not address the potential for confounding and presented analysis on the 
main outcome of interest without adjustment for any potential confounding variables.14, 20, 21   One 
paper adjusted for an inadequate number of confounding variables and was rated as moderate.13  
 All papers contained an adequate description of measurement and assessment methods.  
Most of the papers had outcomes measurements that were both valid and reliable.  For all these 
studies, the ideal measure of race (the exposure variable) is self-report; however, it is unclear 
whether any study used this measure.  An area where the studies differed was whether those 
assessing the angiography report were blinded to the patient’s race.  Studies with blinded 
assessment, improving the equality of measurement between race groups were rated as strong,5, 16  
while the other studies were given a moderate rating.12-15, 20, 21  
 Withdrawals and drop-outs were rarely a concern for these studies, because most of the 
studies were retrospective in nature.  Five of the studies were given strong ratings because of 
minimal rates and an adequate description of withdrawal and loss to follow-up.13-15, 20, 21   The 
paper by Whittle, Kressin and colleagues was given a weak rating as a large portion of the 
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patients who were initially enrolled (having a positive nuclear study) did not receive angiography 
within 90-days and were thus dropped from the study (70% of all initially enrolled patients).16   
The study by Whittle, Conigliaro and colleagues was given a moderate rating as 25% of subjects 
who were enrolled in the retrospective chart review were later removed because detailed charts 
could not be obtained.5   The paper by Budoff and colleagues was given a moderate rating due to 
a limited description of how many patients who received angiography withdrew from the study 
or did not consent to be followed.12  
 The studies varied greatly in strength of analysis as judged by description and 
appropriateness of the analytical techniques as well as the presentation of the findings.  Three 
studies were given strong reviews: they described the analytical methods, presented both 
unadjusted and adjusted findings for the outcome of interest and reported and interpreted the 
significance of the findings correctly.5, 12, 16   Two studies received moderate ratings on analysis.  
The study by Onwuanyi presented findings without adjustment for any potential confounding 
variables but was otherwise strong.20   The study by Shaw and colleagues did not present all the 
findings of the study used to draw conclusions.15   Three studies received weak ratings for quality 
of analysis: all had no adjustment for confounding in addition to other concerns.  The study by 
Peniston and colleagues included results with no confidence intervals and an unclear main 
outcome measure (extent and severity of disease).14   In the study by Liao and colleagues, the 
division of the analysis by different age and sex subgroups was inappropriate and the method of 
significance testing was unclear.13   The study by Afonso and colleagues used an inappropriate 
number of subgroups for the low sample size, and used an alpha of 0.05 with no multiple testing 
adjustments despite the use of seven distinct angiography outcomes.21  
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 For the overall rating of global internal validity, as determined by the preceding six 
subcomponents, six papers were given a moderate rating and two were given a weak rating.  The 
strongest studies (those with the lowest score determined by adding the ratings of the six 
components) were those by Shaw and colleagues and Whittle, Conigliaro and colleagues.5, 15   
The weakest study was the paper by Peniston and colleagues.14   The range of total scores on the 
six components from strongest to weakest was 9 to 13 (with 6 being the strongest possible score 
and 18 being the weakest). 
 The external validity of each study was assessed as its applicability to black and white 
adults in the U.S. undergoing angiography for suspected CAD.  Two studies were given strong 
ratings.  Liao and colleagues had a large, racially diverse sample which included men and 
women undergoing angiography under usual clinical circumstances.13   Shaw and colleagues used 
national database records for data and had a sample representing a large portion of all patients 
undergoing angiography in the U.S.15   Four studies were given moderate ratings and two were 
given poor ratings for external validity.  Common issues with applicability in these studies 
included using only a Veterans Affairs population,5, 14, 16  enrolling only males,5, 14, 16  conducting 
the study in a population with a majority black population,14, 20, 21  only enrolling patients 
undergoing angiography for ACS,5, 16  or excluding patients with ACS.20  
Review of Study Characteristics 
The major characteristics including study population, measurements and results for each 
of the eight studies were reviewed and are summarized in Table 1. 
These eight studies varied in their choice of study population.  Each study population 
included white and black patients undergoing angiography for clinical suspicion of CAD; 
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however, as mentioned in the description of external validity, several studies only examined a 
limited aspect of this population.5, 14, 16, 20   Besides the aforementioned selection criteria from 
these studies (which excluded subjects on the basis of gender or ACS status), the inclusion and 
exclusion criteria for most of the studies was minimal.  As these were studies of rates of 
angiographic CAD, most studies excluded patients with a history of procedures indicating 
definitive previous CAD (including coronary artery bypass grafting and/or percutaneous 
coronary intervention).5, 13, 14, 20, 21   A second common selection criteria was aimed at targeting 
only patients who were undergoing angiography for suspected CAD by excluding those with 
valvular conditions, congenital heart diseases and cardiomyopathies.13-15   Several of the 
investigators limited their study population to those in a middle age range, excluding the elderly 
and young adults.5, 13, 20   The most interesting, and perhaps most unfortunate, selection criteria 
was from the nested study by Onwuanyi and colleagues, who were unable to include patients 
treated with lipid-lowering medications because of the focus of the larger parent study.20   
The outcome measurements varied greatly among the eight included studies.  Onwuanyi 
and colleagues were focused on an outcome of normal coronary arteries, defined as no vessel 
stenoses > 24%.20   Three studies focused only on simple outcomes using a measure of any 
significant stenosis vs. no significant stenosis.5, 12, 15   The other studies used more complicated 
measures to grade overall coronary stenosis based on the location of disease and the amount of 
stenosis present.13, 14, 16, 21   In addition, several of the studies focused on a distinction between 1-, 
2- and 3-vessel disease.5, 13, 14   However, each study incorporated an outcome dichotomizing 
patients into “diseased vs. not diseased,” and this outcome allowed comparison between this 
diverse group of investigations. 
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The eight studies differed in the magnitude and the significance of the association of race 
(black vs. white) with CAD findings on angiography.  On the common measure for all the 
studies, some measure of obstruction vs. no obstruction (or significant stenosis vs. no significant 
stenosis), six studies found that black patients were significantly less likely to have disease than 
white patients.5, 13-16   For example, in the study by Shaw and colleagues which examined 
angiographic findings by race in two large cohorts of patients, the investigators found that after 
adjusting for risk factor differences, among patients without ACS, blacks had 0.47 (95% CI 0.45-
0.50) times the odds of having significant CAD as whites, and among patients without ACS, 
blacks had 0.91 (95% CI 0.87-0.96) times the odds of having significant CAD as whites.  For 
these studies with significant results, relative odds of disease in blacks compared to whites 
ranged from 0.27 (in a group of men with an acute myocardial infarction)5  to 0.91 (in a large 
group of men and women with ACS).15   Three of these studies with significant findings included 
more complicated measures of disease burden (such as an overall stenosis or severity score) in 
their analysis; each demonstrated differences on these measures illustrating a lower burden of 
disease in black patients compared to whites.13, 14, 16    
The study by Afonso and colleagues had no significant results when comparing rates of 
disease in four race-gender subgroups.21    The study by Onwuanyi and colleagues presented 
mixed results.  The authors found that black patients were more likely to have normal coronary 
arteries than whites (OR 1.3 (95% CI 0.93-1.85)) but that this difference was not significant.  
However, when stratifying the patients by gender, they found that black men had 2.09 (95% CI 
1.31-3.32) times the odds of having normal coronary arteries compared to white men while black 
women had 0.63 (95% CI 0.37-1.09) times the odds of having normal coronary arteries 
compared to white women.20   The only other study to have significant results and report analysis 
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stratified by sex did not find these differences between the gender groups.15  Overall, most of 
these cohort studies found that there is a lower disease burden in black patients undergoing 
coronary angiography than their white counterparts. 
DISCUSSION 
Summary of the Evidence 
 The findings of the majority of the literature reviewed indicate that black patients 
undergoing clinically indicated coronary angiography are less likely to have CAD than white 
patients.  Six of the eight studies included in this literature review found lower rates (or adjusted 
odds) of CAD for black patients, and there were significant quality concerns for the two studies 
which found no difference in the rates of angiographic disease between these race groups.  The 
study by Afonso and colleagues was given a poor rating for internal validity, mostly due to lack 
of adjustment for confounding, low sample sizes, and inappropriate analysis.21   The other 
negative study, by Onwuanyi and colleagues, was given a poor rating for external validity as the 
patient population was limited to a hospital with a racial mix not representative of the general 
population, and the study excluded patients with an Acute Coronary Syndrome and those taking 
lipid lowering agents, which represents a large portion of those undergoing angiography.20   
 The magnitude of the race difference in rates of angiographic disease is difficult to 
estimate, as each study had different findings, slightly different outcomes and adjusted for 
different confounding variables in their analysis.  Overall, five moderate quality and one poor 
quality study demonstrate substantial differences between the race groups; therefore, there is a 
fair amount of evidence that indicates that black patients undergoing angiography have a lower 
burden of detectable CAD than their white counterparts. 
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Significance of the Review 
 These findings have several important implications.  First, further investigation is 
warranted to determine causes for the lower rate of disease in blacks as it is difficult to explain in 
the context of other research on racial disparities in CAD.  Besides having a higher morbidity 
and mortality from CAD, black patients are less likely to report for care and may be less likely to 
be referred for angiography than whites.1-3, 7-11   These factors would lead one to conclude that 
among the subset of black patients who do undergo angiography for clinical suspicion of CAD, 
disease would be more likely to be detected than among whites; however, the opposite is true.  
Potential explanations for this paradox include a factor present in black patients undergoing 
angiography that leads to invasive evaluation despite a low likelihood of CAD (such as 
hypertension mimicking CAD on clinical evaluation) or a factor which is more likely to be 
present in black patients that causes CAD outcomes despite a low burden of disease (such as a 
higher likelihood of small unstable plaques). 
 Also, the findings need to be integrated into the larger disparities literature, particularly in 
relation to access to cardiac care.  Several studies indicate that blacks are less likely to receive 
appropriate angiography and revascularization than whites;8, 22, 23  however, in the context of these 
findings, this may simply indicate a lower burden of disease in black patients.  The article by 
Peniston and colleagues included in this review found that black and white patients had the same 
likelihood of revascularization after adjusting for burden of disease.14   Further reviews and 
research could determine if differences in revascularization are purely a reflection of different 
rates of disease or reflect differential use based solely on race. 
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Finally, the results may indicate a differential utility of coronary angiography between 
the races.  Angiography may not be as valuable of a test in the black population; it may not have 
as high a sensitivity and specificity to detect clinically meaningful CAD as it does in the white 
population.  This finding would be important; although angiography followed by percutaneous 
coronary intervention does not necessarily lead to a mortality benefit in those with stable angina, 
the ability to detect stenoses and revascularize appropriate patients with an acute coronary 
syndrome can be lifesaving.24-26   Future research in this area is needed; prospective studies could 
correlate findings on angiography for patients of different races to eventual CAD outcomes to 
determine the prognostic value of angiographic findings in these two populations.   
Limitations 
There are a few limitations to this literature review.  First, this is not a full systematic 
review; the search strategy was not exhaustive and some articles that address the key question of 
this review are likely not included.  However, by using both a Pubmed/Medline search in 
addition to a bibliography review, the included articles likely represent most of the articles that 
have addressed this topic. 
The quality reviews and data-abstraction were also conducted by a single reviewer.  
While dual review is an essential component of formalized and publishable systematic reviews, a 
single review using systematic methods is adequate to gain an understanding of the magnitude 
and quality of the evidence on this topic. 
Conclusions 
Several recent articles have examined angiographic findings by race, and a majority show 
a lower rate of disease in black patients compared to whites.  While the quality of most of these 
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articles is moderate, the finding is both consistent and clinically significant in magnitude.  
Therefore, there is fair evidence that among patients suspected of having CAD, black patients are 
less likely to have significant findings on angiography.  This has significant implications for 
future research: It is essential to determine underlying reasons for these findings, examine the 
relationship of this finding to other studies in the health disparities literature, and determine the 
different value of angiography in the clinical management of suspected CAD in white and black 
patients. 
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Figure 1: Selection of Articles for Review Inclusion 
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, 14 duplicate 
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4 articles excluded for: 
(2)-limited ability to draw direct comparison 
f---:::.~ between white and black patients 
(1)-no consistent use of angiography for 
outcomes measures 
(1)-all patients received fibrinolysis prior to 
angiography 
*adapted from Liberati A et. al. Ann Intern Med 2009; 151 : W-65-W-95. 
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Table 1.  Summary Information and Evidence from each Included Study 
Study Author, Year Study 
Design 
Study Population Study Sample 
Inclusion/Exclusion 
Criteria 
Measurements Significant Results 
Afonso L, Niraj A, 
Veeranna, V, Fakhry H, 
Pradhan, J. 2008 
Retrospective 
cohort study 
-N=640 
-428 black patients (66.9%) 
-212 white patients (33.1%) 
 
-consecutive subjects referred 
for coronary angiography to 
same tertiary care center 
between January-October 2005 
 
-962 patient records 
examined for inclusion 
-excluded all patients of 
races other than black 
and white  
-excluded all patients 
with history of CABG  
-significant lesions 
defined as >50% in LMA 
or >70% in other arteries 
-high-risk coronary 
anatomy defined as >50% 
in LMA or significant 
lesions in ≥ 3 vessels 
-Duke Myocardial 
Jeopardy Score = 0-12 
score based on stenosis in 
6 vessel segments 
 
-no adjusted analysis 
-all results reported as comparisons 
between four race-gender 
subgroups 
-no significant differences between 
significant lesions, high-risk 
coronary anatomy or Duke 
Jeopardy score between groups 
 
Shaw L, Shaw R, Merz 
CN, et. al. 2008 
 
Retrospective 
cohort study 
2 study populations: 
 
1)  N= 375,886 
-24,998 black patients (6.7%) 
-338,252 white patients (90.0%) 
-consecutive patients referred for 
coronary angiography with 
stable chest pain at 388 
participating hospitals from 
2000-2002 
 
2)  N= 350,329 
-23,382 black patients (5.2%) 
-412,918 white patients (91.7%) 
-consecutive patients referred for 
coronary angiography with ACS 
at 388 participating hospitals 
from 2000-2002 
-examined all patients 
from 388 participating 
hospitals with variables 
recorded in ACC-NCDR 
registry for inclusion 
-excluded patients 
receiving angiography 
prior to valvular surgery 
-excluded patients 
receiving angiography 
for evaluation of other 
heart diseases 
(transplant, congenital, 
cardiomyopathy) 
-Significant CAD defined 
as stenosis ≥ 70% in 
LAD, LCx, or RCA 
 
-analysis adjusted for 
CAD risk factors and non-
cardiac atherosclerosis 
1) For non-ACS patients: 
Unadjusted: 
-52.2% of black men had 
significant CAD 
-67.6% of white men had 
significant CAD 
-41.7% of black women had CAD 
-50.0% of white women had CAD 
Adjusted: 
-blacks had 0.47 (95% CI 0.45-
0.50) times the odds of having 
significant CAD as whites 
2) For ACS patients 
Unadjusted: 
-64.2% of black women had 
significant CAD 
Adjusted: 
-blacks had 0.91 (95% CI 0.87-
0.96) times the odds of significant 
CAD as whites 
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Whittle J, Conigliaro C, 
Good B, Hanusa B, 
Macpherson D.  2002 
Retrospective 
cohort study 
-N=628 
-313 black patients (50.0%) 
-315 white patients (50.0%) 
 
-subjects who had an ACS and 
received angiography during 
hospitalization from 1989-1995 
at 6 geographically diverse VA 
hospitals 
-all eligible black patients 
included, with equal number of 
white patients selected  
-white patients matched on age, 
center, primary diagnosis and 
year of discharge 
-examined 3,137 
potential subjects records 
-included only those who 
met standard criteria for 
ACS 
-only males 
-only patients over age 
30 
-excluded those with 
prior PCTA/CABG 
-excluded those 
originally admitted for 
reasons other than ACS 
-Significant obstruction 
defined as  ≥ 50% in 
LMA or  ≥ 70% in other 
major vessels 
-also examined 2 and 3 
vessel significant disease  
 
-analysis adjusted for 
CAD risk factors and 
AMI location 
 
1)for patients with AMI:  
Unadjusted: 
-19% of black men had no 
significant obstruction compared to 
7% of white men (p=0.001) 
Adjusted: 
-black men had 0.27 (95% CI 0.12-
0.63) times the odds of significant 
obstruction as white patients 
2) for patients with unstable 
angina: 
Unadjusted: 
-33% of black men had no 
significant obstruction compared to 
17% of white men 
Adjusted: 
-black men had 0.40 (95% CI 0.23-
0.70) times the odds of significant 
obstruction compared to white men 
Onwuanyi A, Abe O, 
McMahon D, et. al. 2006 
Prospective 
cohort study 
-N=560 
-226 black patients (40.4%) 
-334 white patients (59.6%) 
 
-consecutive patients from 1991-
1994 from 2 hospitals who 
underwent angiography for 
suspected CAD 
 
-nested study within the large 
Harlem-Bassett cohort study 
 
-examined all patients 
within the cohort who 
underwent angiography 
-excluded patients age > 
70 
-excluded patients with 
recent MI 
-excluded patients who 
had received thromolysis 
-excluded previous PCI 
patients 
-excluded those with 
previous CABG 
** main cohort excluded 
those who use lipid-
lowering agents 
-Normal coronary arteries 
defined as no segment (of 
15 coronary artery 
segments assessed) with 
stenosis > 24% 
 
-no adjusted analysis 
-overall, 42.9% of black patients 
had normal coronary arteries 
compared to 36.5% of white 
patients.  (OR 1.3 (95% CI 0.93-
1.85)). 
-Black men had 2.09 (95% CI 
1.31-3.32) times the odds of having 
normal coronary arteries compared 
to white men  
-Black women had 0.63 (95% CI 
0.37-1.09) times the odds of having 
normal coronary arteries compared 
to white women  
Peniston R, Lu D, 
Papandemetriou V, 
Fletcher R. 2000 
Retrospective 
cohort study 
-N=1,460 
-726 black patients (49.7%) 
-734 white patients (50.3%) 
 
-consecutive eligible patients 
-1688 records screened 
for enrollment 
-only males included 
-only black and white 
patients 
-Extent of disease score 
based on 27 anatomic 
segments (CASS method) 
-Severity score based on 
27 anatomic segments 
-37% of black men had no disease 
compared to 19% of white men 
(p<0.001). 
-black men less likely to have 2- 
and 3-vessel disease (p<0.001). 
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referred for coronary 
angiography from 1986-1992 in 
one VA hospital 
-only one catheterization 
for each patient included 
-excluded patients with 
history of CABG 
-excluded patients 
receiving angiography 
for valvular disease and 
prior to 
electrophysiology study 
-1, 2, 3 vessel disease 
defined as >50% stenosis 
in a vessel 
-LMA disease defined as 
>50% stenosis 
-no disease defined as no 
stenosis >50% in any 
vessel 
 
-no adjusted analysis 
-5% of black men had LMA 
disease compared to 8% of white 
men (p<0.001) 
-Extent and Severity of disease 
scores lower in black men 
(p<0.001) 
 
 
Whittle J, Kressin N, 
Peterson E, et al. 2006 
Prospective 
cohort study 
-N=311 
-52 black patients (16.7%) 
-259 white patients (83.3%) 
 
-patients with positive nuclear 
scans who later had angiography 
from 1999-2001 at several VA 
hospitals 
 
-nested within the CDMS 
prospective cohort study 
 
-2.335 patients with 
positive nuclear studies 
screened for enrollment 
-only males included 
-only white and black 
patients 
-excluded patients with 
altered mental status 
-excluded patients with 
cardiac procedures in 
last 6 months 
-excluded patients 
without follow-up 
angiography within 90 
days (only 30.3% of 
otherwise eligible 
patients) 
-No disease defined as no 
stenosis ≥ 70% 
-Moderate stenosis 
defined as ≥ 70% stenosis 
in one vessel with 
proximal LAD affected 
-Minimal stenosis defined 
as ≥ 70% stenosis in one 
vessel without proximal 
LAD affected 
-Severe stenosis defined 
as LMA stenosis ≥70% or 
all three vessel systems 
with a stenosis of ≥70% 
 
-analysis adjusted for age, 
site, other conditions, 
angina, previous CAD, 
medical therapy, results of 
perfusion study and 
physicians global estimate 
of risk 
Unadjusted analysis: 
-26.9% of black patients have 
severe disease compared to 39.4% 
of white patients (p=0.01) 
-36.5% of black patients have no 
disease compared to 23.6% of 
white patients (p=0.01) 
Adjusted analysis: 
-whites are 2.77 (95% CI 1.29-
5.93) times more likely to have 
significant obstruction compared to 
blacks 
Liao Y, Ghali, J, Berzins 
I, Cooper R. 2001 
Retrospective 
cohort study 
-N=4,417 
-1,793 black patients (40.6%) 
-2,624 white patients  (59.4%) 
 
-consecutive patients from 1990-
1997 from a single institution 
who had catheterization for 
suspected CAD 
-4,883 records reviewed 
for inclusion 
-included only white and 
black patients 
-included only those age 
> 35 
-excluded patients with 
multiple catheterizations, 
-significant disease 
defined as stenosis ≥ 50% 
in any vessel 
-1, 2 and 3 vessel disease 
-overall stenosis score 
(defined by the sum of the 
luminal stenosis in all 
vessels with LMA 
1) For ages 35-54: 
-41% of blacks had no significant 
disease compared to 34% of whites 
(p<0.05) 
-For those with disease, rates of 
1,2,3 vessel stenosis similar 
-severity scores similar for those 
with disease 
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previous CABG, 
previous PCI 
-also excluded patients 
with valvular disease, 
cardiomyopathy, 
congenital heart disease 
and endocarditis 
stenosis doubled) 
 
-analysis in 2 age cohorts  
-all analysis adjusted for 
sex 
2) For age >55: 
-32% of blacks had no significant 
disease compared to 17% of whites 
(p<0.05) 
-blacks with CAD more likely to 
have 1-vessel disease than whites 
and less like to have 3-vessel 
disease (p<0.05) 
-higher severity score in whites 
(p<0.05) 
Budoff M, Yang T, 
Shavelle S, Lamont D, 
Brundage B. 2002 
Prospective 
cohort study 
-N=782  
-108 black patients (13.8%) 
-453 white patients (57.9%) 
 
-patients from a single institution 
(unclear study period) 
undergoing coronary 
angiography for clinical 
indications followed by electron 
beam tomography within 3 
months 
-included white, black, 
Hispanic and Asian 
patients 
-included any indication 
for catheterization 
-excluded those who did 
not have EBT scans 
within 3 months 
-obstruction on 
angiography defined as 
>50% obstruction in any 
vessel 
 
-adjusted for CAD risk 
factors 
Unadjusted analysis: 
-49% of blacks had obstruction on 
angiography compared to 71% of 
whites (p<0.001) 
Adjusted analysis: 
-blacks had 0.48 (0.29-0.78) times 
the odds of obstruction on 
angiography as whites 
 
 
 
Abbreviations key: 
CAD: Coronary Artery Disease 
CABG: Coronary Artery Bypass Grafting 
PCTA: Percutaneous Transluminal angioplasty 
PCI: Percutaneous Coronary Intervention 
LMA: Left Main Artery 
LAD: Left Anterior Descending 
LCx: Left Circumflex Artery 
RCA: Right Coronary Artery 
ACS: Acute Coronary Syndrome 
AMI: Acute Myocardial Infarction 
MI: Myocardial Infarction 
ACC-NCDR: American College of Cardiology-National Cardiovascular Disease Registry 
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Table 2.  Summary of Quality Assessment Scores for Each Study   
Each study was rated 1-3 on each category.  1=strong study, 2=moderate study, 3=weak study 
Study Authors, 
Year 
Study 
Design 
Selection 
Bias 
Confounding Measurement 
Bias 
Withdrawals 
and Drop-
Outs 
Appropriate 
Analysis 
Global 
Assessment 
of Quality 
(internal 
validity) 
Assessment 
of External 
Validity 
 
Afonso L, Niraj A, 
Veeranna V, Fakhry 
H, Pradhan J. 2008 
 
2 
 
1 
 
3 
 
2 
 
1 
 
3 
 
3 
 
2 
Shaw L, Shaw R, 
Merz CN, et. al. 2008 
 
 
2 
 
1 
 
1 
 
2 
 
1 
 
2 
 
2 
 
1 
Whittle J, Conigliaro 
C, Good B, Hanusa 
B, Macpherson D.  
2002. 
 
2 
 
2 
 
1 
 
1 
 
2 
 
1 
 
2 
 
2 
Onwuanyi A, Abe O, 
McMahon D, et. al. 
2006 
 
2 
 
1 
 
3 
 
2 
 
1 
 
2 
 
2 
 
3 
Peniston R, Lu D, 
Papandemetriou V, 
Fletcher R. 2000 
 
2 
 
1 
 
3 
 
2 
 
1 
 
3 
 
3 
 
2 
Whittle J, Kressin N, 
Peterson E, et al. 
2006. 
 
2 
 
 
2 
 
1 
 
1 
 
3 
 
1 
 
2 
 
3 
Liao Y, Ghali, J, 
Berzins I, Cooper R. 
2001 
 
2 
 
1 
 
2 
 
2 
 
1 
 
3 
 
2 
 
1 
Budoff M, Yang T, 
Shavelle S, Lamont 
D, Brundage B. 2002 
 
2 
 
2 
 
1 
 
2 
 
2 
 
1 
 
2 
 
2 
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ABSTRACT: 
Background.  Black patients in the U.S. undergoing angiography for suspected coronary artery 
disease (CAD) have consistently been found to have less disease than whites.  As the effects of 
hypertension are greater in blacks than whites, and hypertensive heart disease may mimic CAD 
and lead to catheterization, we examined the association between race and hypertension as an 
explanation for the disparities in angiographic CAD. 
Methods.  Using an academic hospital’s institutional database, we studied patients undergoing 
first-time elective angiography from 2001-2008.  Using multivariable logistic regression with 
data on patient demographics, CAD risk factors and coronary stenoses we compared rates of 
angiographic disease for blacks and whites, creating models separately for patients with and 
without hypertension.  We then tested the significance of an interaction term between race and 
hypertension on angiographic findings. 
Results.   We identified 1,203 black and 2,538 white patients who underwent initial elective 
angiography.  Black patients were less likely to have a significant stenotic lesion (≥50% stenosis 
in the left main coronary artery or ≥70% stenosis elsewhere) than whites (adjusted odds ratio 
(aOR) 0.54; 95% confidence interval (CI) 0.44-0.66).  Among patients with hypertension this 
difference was exaggerated (aOR 0.47; 95% CI 0.38-0.59).  However, among patients without 
hypertension, the odds of having a significant lesion were similar in blacks and whites (aOR 
0.95; 95% CI 0.60-1.53).  The interaction term for race and hypertension was confirmed as 
statistically significant. 
Conclusions.  Among patients electively referred for angiography, hypertension and its effects 
may explain the lower rate of CAD found in blacks compared to whites.   
32 
 
INTRODUCTION 
Significant racial disparities exist in the clinical evaluation, management and outcomes of 
coronary artery disease (CAD) in the United States (U.S.).  Most research in this area has 
focused on the disparate clinical burden of disease and poor outcomes in blacks compared to 
whites.  Blacks have been shown to have higher rates of traditional CAD risk factors and co-
morbidities,1-4  face greater barriers to care,4  and often receive less appropriate invasive 
management.2-9  These factors contribute to a substantially higher age-adjusted death rate from 
CAD in blacks compared to whites.10   Despite these disparities, in several studies examining 
angiographic burden of CAD by race, blacks have been found to have less detectable coronary 
plaque than whites.7, 11-13   The reasons for the lower rate of angiographic findings in this 
population remain unclear. 
 A potential explanation for racial differences in angiographic disease is that the effects of 
hypertension in blacks may disproportionately, in comparison to whites, mimic the symptoms 
and signs of CAD, leading to angiographic evaluation and negative study findings.   Black 
patients in the U.S. have hypertension of greater severity,14, 15  with earlier age of onset, 16-20  
leading to higher rates of end-organ damage, including hypertensive heart disease, compared to 
other racial groups.14, 16   Hypertensive damage to the heart, including microvascular disease and 
left ventricular hypertrophy (LVH),11  can cause chest pain as well as resting and exercise 
electrocardiogram (ECG) changes.11, 21-25   Thus the relative severity of hypertension in blacks 
may lead to invasive CAD evaluations prompted by the effects of hypertension rather than 
coronary insufficiency.  This may be particularly true in the subset of patients undergoing 
cardiac catheterization without a high likelihood of disease: those without a confirmed history of 
CAD and not experiencing an Acute Coronary Syndrome (ACS). 
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 In order to explore this novel hypothesis, we sought to examine patients undergoing 
initial elective angiographic evaluation to (1) confirm differences in angiographically detected 
CAD between black and white patients, (2) examine differences in risk factors and 
characteristics by race, and most importantly, (3) examine whether hypertension is associated 
with black-white differences in disease found at angiography and therefore might explain the 
lower rate of angiographic disease found in blacks. 
METHODS 
Study Design and Data Collection 
 This study is a secondary analysis of a comprehensive database of all cardiac 
catheterizations performed at a single academic medical center in the southeastern U.S.  The 
hospital uses Apollo software, a proprietary reporting program (Lumedx, inc. Oakland, CA) for 
data capture, storage and reporting to the National Cardiovascular Disease Registry (NCDR).26  
Prior to each catheterization procedure, patient demographics are entered into the database by a 
registration clerk and trained catheterization lab technicians and nurses while patient medical 
history and the clinical circumstances of the catheterization are entered by cardiology fellows.  
Following the procedure, detailed information on coronary anatomy findings, including the 
maximum percent stenosis found within each vessel, is entered by the physician who performed 
the procedure.    The data are subsequently reviewed by a research nurse who is responsible for 
the integrity and consistency of the data.  Global data reviews are performed annually to ensure 
accuracy. 
Study Sample 
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 The database included 29,433 catheterization procedures performed on 18,553 unique 
individuals from its inception through December 16, 2008. We identified the first registry-listed 
cardiac catheterization for each individual, and then selected the 10,627 of these that were 
performed after August 1, 2001 when data on coronary stenosis and severity were first routinely 
recorded. Of these procedures, 8,530 included coronary angiography: 2,305 for black patients, 
5,597 for white patients, 602 for patients of other races and 26 for patients of unknown race. For 
these 7,902 black and white patients undergoing a first angiography at this hospital, 1,780 were 
excluded for having previously confirmed CAD: 753 were excluded for having previous 
angiographic intervention, 373 for having a history of coronary artery bypass surgery, and 654 
for having a history of myocardial infarction.  Another 2,381 were excluded for presenting with 
an Acute Coronary Syndrome (ACS), as these patients have a diagnosis with a high likelihood of 
significant CAD and an indication for urgent or emergent catheterization.  These exclusion 
criteria reduced the sample to 3,741 patients in an attempt to target the population undergoing 
first angiography under elective circumstances for suspected, but not yet confirmed, CAD. 
Study Variables of Interest 
 The outcome variables “any stenosis” and “significant stenosis” were created from 
existing variables in the dataset defining stenosis in each major coronary artery segment assessed 
at angiography (left main artery (LMA), proximal left anterior descending (LAD), mid-distal 
LAD, left circumflex (LCx), right coronary artery (RCA)).  The outcome of “any stenosis” was 
defined as any identified atherosclerotic lesions (>0% stenosis) in any of the segments.  The 
outcome of “significant stenosis” was defined as either ≥50% stenosis in the LMA or ≥70% 
stenosis in any other segment. 
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 Race information for each patient was entered by catheterization lab nurses and fellows, 
typically by copying race information recorded in the hospital’s electronic patient medical 
records (EMR). Race information in the EMR is available in two locations: on a patient 
demographics page that presents information recorded by registration clerks for administrative 
purposes and within physicians’ clinical notes.  In most cases it is likely not self-reported. 
 Covariates for the multivariable analyses included age, sex and traditional CAD risk 
factors (hypertension, diabetes, hyperlipidemia, smoking status and family history of premature 
cardiovascular disease).  Analysis was originally conducted including patient BMI and history of 
congestive heart failure (CHF) as covariates.  BMI was not entered into the multivariable model 
because of its lack of association with positive angiographic findings.  History of CHF was also 
not entered because, as a consequence of long-term hypertension, it may over-correct for the 
explanatory variable of interest.  All the independent variables are binary with the exception of 
age (continuous in years) and patient BMI (continuous in kg/m²).   
Analysis Strategy 
 We compared characteristics and CAD risk factors among patients in our sample by race 
and tested for significance using Pearson’s Chi-square test within categories and 2-tailed t-tests 
for continuous measures.  We dichotomized age and BMI to report associations between each 
independent variable (including race) and the outcomes as proportions, using Pearson’s Chi-
square to test for significant differences between proportions.   
 Logistic regression modeling was used to examine the independent association of race 
with each of the two outcomes while adjusting for traditional CAD risk factors and 
demographics.  We then stratified the logistic regression by patient history of hypertension.  For 
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all logistic regression analyses, we report adjusted odds ratios (OR) with 95% confidence 
intervals (CI).  To examine the potential effect modification by hypertension on the relationship 
between race and the outcomes of angiographic stenosis we repeated the logistic model for those 
with and without hypertension combined and included an interaction term between race and 
hypertension, testing for significance (using the Wald test).  Patients with missing data were 
excluded from the multivariable models. 
 Data analysis was performed using STATA (version 10.1; College Station, TX) statistical 
software program.  All statistical testing was two-sided with the level of significance set at 
p≤0.05.  This study was approved by the Biomedical Institutional Review Board of the 
University of North Carolina at Chapel Hill. 
RESULTS 
Sample Patient Characteristics and Comparison by Race 
 Of the 3,741 patients undergoing initial elective catheterization, approximately one-third 
(32.2%) were black.  Slightly over half (52.2%) were male and a majority (70.8%) had a history 
of hypertension.  Black patients in the sample were significantly younger, had higher BMI, and 
greater prevalence of both diabetes and hypertension (Table 1).  Rates of smoking and 
hyperlipidemia were comparable between black and white patients.   
Coronary Artery Disease Risk Factors 
Most traditional risk factors for CAD (including older age, smoking, hypertension, 
hyperlipidemia, diabetes and family history) were associated with positive findings on 
angiography (Table 2).  For example, among patients with hypertension, 34.3% had a significant 
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stenotic lesion on angiography compared to 23.6% of patients without hypertension (p<0.001).  
Interestingly, obese patients (BMI ≥ 30 kg/m²) were less likely to have evidence of a significant 
stenotic lesion in comparison with non-obese patients (26.7% vs. 35.6%, p<0.001).  This finding 
was also noted for the outcome of having any stenosis. 
Black Patients and Low Angiographic Burden of Disease 
Among the entire sample, 63.5% of the patients had disease detected in at least one major 
vessel on angiography, while 30.4% were found to have significant stenosis.   Black patients had 
lower prevalence of disease than whites by both outcome measures.  Black patients had 0.52 
(95% CI 0.45-0.61) times the odds of having any stenosis compared to whites and 0.47 (95% CI 
0.40-0.55) times the odds of having significant stenosis compared to whites. 
The relatively lower prevalence of angiographic disease among blacks did not change 
substantially after adjusting for demographics and CAD risk factors, where black patients had 
0.59 (95% CI 0.49-0.71) times the odds of having any detected stenotic lesions compared to 
whites and 0.54 (95% CI 0.44-0.66) times the odds of having significant stenosis compared to 
whites. 
Race, Hypertension and Burden of Disease 
In the adjusted multivariable models stratified by patient history of hypertension, among 
those patients with hypertension, blacks had 0.50 (95% CI 0.41-0.62) times the odds of having 
any stenotic lesions and 0.47 (95% CI 0.38-0.59) times the odds of having significant stenosis 
(Table 3).  In contrast, among the patients without a history of hypertension blacks had roughly 
equivalent odds as whites of having any stenosis (OR 0.93 (95% CI 0.63-1.36)) or a significant 
stenosis (OR 0.95 (95% CI 0.60-1.53)). 
38 
 
The significance of the difference between hypertensive and non-hypertensive patients in 
the size of the black-white relative odds of having any disease and significant disease was 
confirmed in a multivariable model that included all patients (hypertensives and non-
hypertensives) and an interaction term for race and hypertension. The interaction terms were 
significant in the models with both any stenosis (p=0.024) and significant stenosis (p=0.034) as 
the outcomes. 
All models were also tested with the addition of the covariates BMI and history of CHF.  
The addition of these two covariates had minimal effects on the findings.   
DISCUSSION 
 In this study, we investigated the possible role of hypertension in explaining black-white 
differences in angiographically detectable coronary disease by examining data from an 
institutional database in a sample of black and white patients undergoing non-emergent coronary 
angiography for suspected CAD.  Our study confirmed that black patients were significantly less 
likely to have any detected disease or any significant stenosis (≥50% in LMA or ≥70% in other 
artery segments) on coronary angiography, but to explore our novel hypothesis, we stratified 
patients by history of hypertension and then tested the racial differences in angiographic CAD.  
Among the patients with hypertension, blacks remained less likely than whites to demonstrate 
any disease or any significant disease.  Among the patients without hypertension, however, there 
was not a significant black-white difference in the rate of detected disease.  This finding was 
supported by the significance of a statistical test of the interaction between hypertension and race 
for both outcomes.  Thus it appears that hypertension may be related to the common finding that 
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blacks undergoing elective catheterization for possible CAD have a lower burden of 
angiographic disease.   
Our sample’s patients resemble those of previous studies assessing black-white 
differences in CAD risk factors.27, 28   Black patients were more likely to have hypertension, 
diabetes and elevated BMI than white patients, but the groups had roughly equivalent rates of 
smoking and hyperlipidemia.  In our study stample, we also found, as expected, that traditional 
CAD risk factors were associated with the outcomes of stenotic disease.  Interestingly, non-obese 
patients had higher rates of detected CAD than obese patients.  In several other studies, BMI has 
been found to have an inconsistent association with the presence of coronary atherosclerosis.29-32    
Significance of Results 
We are not aware of any studies to date that have examined explanations for the lower 
incidence of angiographically detected CAD and higher rate of negative diagnostic studies in 
black patients.  Hypertension, and its differential severity between races, provides a plausible 
explanation for these findings, as its effects and associated symptoms may lead to catheterization 
in patients without CAD.  While hypertension is an established risk factor for CAD itself, its 
effects extend beyond increasing the likelihood of atherosclerosis or plaque rupture in the 
coronary arteries, and include both microvascular damage and end-organ disease.  Rates of both 
elevated blood pressure itself and these long-term effects have been shown to be higher in blacks 
relative to whites.14, 15, 19   Hypertensive disease can certainly mimic CAD on clinical presentation: 
microvascular disease has been postulated to cause chest pain,21, 22  and LVH can be responsible 
for a symptomatic presentation including chest pain and ECG changes.11, 23-25   Hypertension can 
also lead to false positive results on initial diagnostic evaluation; the specificity of many 
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noninvasive tests for CAD have been shown to be quite low in hypertensive patients.33, 34   
Moreover, patients with hypertensive heart disease, including LVH and eventual heart failure, 
may appear to be sicker and at higher risk of cardiac death, prompting clinicians to undertake 
catheterization.  
 We feel it is important to examine the potential causes of black-white differences in rates 
of CAD found during angiography.  Coronary angiography is an invasive procedure, and in our 
sample, black patients—particularly those with a history of hypertension—appear to have a 
disproportionately high rate of receiving procedures with negative results. Such procedures may 
be considered unnecessary, costly, potentially harmful, and distracting from other diagnostic 
strategies appropriate to finding the actual cause of the patient’s symptoms.  However, it is 
important to note that these findings do not temper or dispute the concerning evidence that many 
blacks in the U.S. do not receive cardiac catheterization when it is clearly indicated.4, 6  
Further research, utilizing catheterization findings in conjunction with continuous BP 
measures over time and data on hypertension-related variables (such as LVH, ECG 
abnormalities, age of hypertension onset, endothelial dysfunction and others), may elucidate a set 
of specific factors that contribute to the disproportionately higher rate of negative studies in this 
subset of black patients.  Such information may eventually support the development of 
individualized algorithms for clinical evaluation and management of suspected CAD, taking both 
race and the impact of hypertension into account.   
 Limitations 
 Race classification was based on information from the hospital records rather than self-
identification, which, although not ideal, is the case with racial classification in most hospitals in 
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the U.S.35   While hospitals have been shown to misclassify race on a small but significant 
number of individuals,36  the effect of this misclassification would be nondifferential and tend to 
minimize rather than exaggerate race group differences. 
 The use of race as an exposure variable also presents many difficulties.  Race is 
challenging to study as it is a social categorization that does not necessarily reflect genetic 
variation.37, 38   The diverging effect of hypertension in white and black subjects on angiographic 
outcomes is complex and likely represents care and access disparities in addition to a myriad of 
health behavior, socioeconomic, and historical differences between these groups.  Biological 
differences related to hypertension may contribute but are likely not the primary cause of these 
findings.38, 39   In our study, we included race as a stand-alone variable, without data to assess 
which aspects of race may be responsible for study findings. 
 The definition of hypertension as a variable also has important limitations.  As it was 
recorded in the database, patients were grouped according to personal history of hypertension.  
We did not have information on patient blood pressure over time and could not estimate the 
direct effect of hypertensive myocardial damage, as it is related to race, on the outcomes. 
Conclusions 
 In this study we assessed how hypertension might explain the racial differences in 
likelihood of angiographic disease.  We found that black-white differences in angiographic CAD 
can be demonstrated only for patients with a history of hypertension, with rates of coronary 
stenosis being equivalent for blacks and whites without hypertension.  These findings apply to 
patients undergoing catheterization suspected to have CAD with no indication for emergent 
catheterization.  These are patients in whom clinical decision making is more difficult, in whom 
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the rate of negative angiography is already generally high,40  and for whom catheterization is 
elective and clinicians might consider other diagnostic modalities.  Among such electively 
referred patients, it appears that hypertension or its effects may be responsible for the 
disproportionate number of negative angiographic studies among blacks.  These findings suggest 
that with additional studies on the connection between race, hypertension and angiographic 
disease, there may be ways to refine the clinical circumstances under which coronary 
angiography is most and least likely to contribute important and useful information in the 
evaluation of chest pain and CAD-like symptoms in black patients. 
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TABLES 
Table 1. Patient Characteristics by Race 
Characteristic  Black mean 
or %  
(n=1,203) 
White mean or 
% 
(n=2,538)  
p-value  
Age in years  54.5  59.9  <0.001  
% Male  45.3  55.6  <0.001  
BMI (kg/m²)  32.4  29.0  <0.001  
% with smoking history  58.0  60.0  0.270  
% with hypertension  81.6  65.7  <0.001  
% with hyperlipidemia 48.4  49.4  0.588  
% with diabetes  35.5  21.7  <0.001  
% with positive family 
history of CAD  
31.5  39.8  <0.001  
% with CHF  25.6  13.1  <0.001  
BMI=body mass index 
CAD=coronary artery disease 
CHF=congestive heart failure 
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Table 2.  Associations Between Patient Characteristics and Angiographically Detected 
Stenosis  
CharacteristicAge 
(10 years)  
Any Stenosis 
(% with outcome))  
p-value Significant Stenosis 
(% with outcome)  
p-value 
Age  
     ≥60 (n=1,702) 
     <60 (n=2,039) 
 
79.0% 
50.6% 
 
<0.001 
 
41.1% 
23.2% 
 
<0.001 
 
Sex 
     Male (n=1,955) 
     Female (n=1,786) 
 
71.1% 
55.3% 
 
<0.001 
 
39.2% 
22.8% 
 
<0.001 
BMI (kg/m²)  
     ≥30 (n=1,800) 
     <30 (n=1,921) 
 
60.2% 
66.6% 
 
<0.001 
 
26.7% 
35.6% 
 
<0.001 
Smoking hx  
     Former/Current   
     (n=2,106) 
     Never (n=1,444) 
 
67.1% 
 
56.8% 
 
<0.001 
 
35.8% 
 
25.9% 
 
<0.001 
Hypertension  
     Yes (n=2,598) 
     No (n=1,072) 
 
68.4% 
51.5% 
 
<0.001 
 
34.3% 
23.6% 
 
<0.001 
Hyperlipidemia 
     Yes (n=1,703) 
     No (n=1,769) 
 
73.5% 
54.0%  
 
<0.001 
 
38.7% 
26.1% 
 
<0.001 
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Diabetes  
     Yes (n=958) 
     No (n=2,710) 
 
72.6% 
60.4% 
 
<0.001 
 
37.6% 
28.9% 
 
<0.001 
Family hx of CAD 
     Yes (n=1,262) 
     No (n=2,137) 
 
65.5% 
62.0% 
 
0.039 
 
33.0% 
29.7% 
 
0.043 
CHF  
     Yes (n=624) 
     No (n=3,024) 
 
55.3% 
65.2%  
 
<0.001 
 
22.0% 
33.1% 
 
<0.001 
     
BMI=body mass index 
CAD=coronary artery disease 
CHF=congestive heart failure 
 
 
 
 
 
 
53 
 
Table 3. Odds Ratios (OR) of Angiographically Detected Stenosis for Black Patients 
Relative to Whites, Stratified by Hypertension* 
Characteristic  OR of any 
stenosis** 
p-value^  OR of sign. 
stenosis**  
p-value^  
Patients with 
hypertension  
(n=2,112) 
0.50 (0.41-0.62)  <0.001  0.47 (0.38-0.59)  <0.001  
Patients without 
hypertension 
(n=909)  
0.93 (0.63-1.36)  0.699 0.95 (0.60-1.53) 0.846  
*Adjusted for age, sex, hyperlipidemia, diabetes, smoking status, family history 
**OR presented for blacks relative to whites 
^ p-values reported for significance of association between race and outcomes in logistic models 
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